
QIAGEN N.V. QGEN
€ 44.86
-0.63%
QIAGEN N.V. DIO | QGEN
DIO Jährlich QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 134 | 122 | 189 | 165 | 141 | 132 | 117 | 116 | 108 | 101 | 110 | 101 | 96.1 | 115 | 115 | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 189 | 96.1 | 124 |
DIO anderer Aktien in der Diagnostik & Forschung
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Personalis
PSNL
|
12.1 | $ 14.29 | -2.96 % | $ 1.28 B | ||
|
Quidel Corporation
QDEL
|
133 | $ 8.31 | -6.84 % | $ 350 M | ||
|
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M | ||
|
Waters Corporation
WAT
|
528 | $ 438.11 | -4.11 % | $ 26.1 B | ||
|
Neuronetics
STIM
|
20.4 | $ 1.24 | -4.44 % | $ 81.8 M | ||
|
Trinity Biotech plc
TRIB
|
212 | $ 6.24 | 13.76 % | $ 2.24 B | ||
|
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | ||
|
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M | ||
|
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | ||
|
Twist Bioscience Corporation
TWST
|
62.4 | $ 103.2 | -7.54 % | $ 6.46 B | ||
|
Organovo Holdings
ONVO
|
371 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
216 | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
87.6 | - | -0.91 % | $ 14.7 B | ||
|
Soleno Therapeutics
SLNO
|
160 | - | - | $ 2.69 B | ||
|
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | ||
|
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | ||
|
Meridian Bioscience
VIVO
|
182 | - | - | $ 1.49 B | ||
|
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
T2 Biosystems
TTOO
|
71.2 | - | -39.35 % | $ 313 K | ||
|
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
126 | - | - | $ 21.2 M | ||
|
Quotient Limited
QTNT
|
341 | - | -11.32 % | $ 1.1 M | ||
|
Burning Rock Biotech Limited
BNR
|
137 | $ 13.46 | 1.05 % | $ 142 M | ||
|
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | ||
|
Surmodics
SRDX
|
166 | - | - | $ 608 M | ||
|
IDEXX Laboratories
IDXX
|
84.3 | $ 675.24 | -2.09 % | $ 54.3 B | ||
|
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | ||
|
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | ||
|
Agilent Technologies
A
|
110 | $ 169.82 | -3.21 % | $ 48.2 B | ||
|
Charles River Laboratories International
CRL
|
35.3 | $ 314.38 | -4.13 % | $ 15.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 257.78 | -0.4 % | $ 28.6 B | ||
|
Danaher Corporation
DHR
|
87.6 | $ 220.3 | -3.19 % | $ 157 B | ||
|
DexCom
DXCM
|
115 | $ 79.02 | -1.46 % | $ 30.8 B |